Maturation Inhibitor(s)
Audio
Maturation inhibitors (MIs) are a class of drugs that act during the last stage of the HIV life cycle. MIs bind to a long HIV protein chain called Gag and prevent the HIV protease enzyme from breaking up the Gag protein chain. By blocking protease activity, MIs prevent immature HIV from becoming a mature virus that can infect other CD4 cells. Currently, MIs are still under clinical investigation, and there are no MIs approved by the U.S. Food and Drug Administration (FDA).
Download Glossary
-
English Version PDF(3.13MB)
-
Spanish Version PDF(3.16MB)